NASDAQ: BIIB · Drug Manufacturers - General
Over the past week, Biogen (BIIB) logged 17 mentions across Reddit, X and news, and the read is an Adanos Hold. The crowd averages 43% bullish but is deeply split: News runs 54% bullish while X sits at just 25%. Wall Street is more constructive, with 22 of 35 analysts rating BIIB a buy.
There is little buzz around BIIB this week and little agreement on direction, which is why it reads as a Hold.
Wall Street’s 63% buy share sits next to a crowd that ranges from X at 25% to News at 54%. No other tracker puts the two side by side.
Across 35 analysts the consensus is a Strong Buy: 22 buy calls against 1 sell, with an average 12-month price target of $238.18.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits just below the neutral line, momentum is cooling and the 3 sources disagree sharply, so the read is Hold rather than a clear buy or sell.
Analysts sit 20 points above the crowd average of 43%, the professionals are more constructive than retail. The split is inside the crowd: News reads 54% bullish while X sits at 25%, a 29-point spread that single-source trackers miss.
Over the 30-day window, Biogen (BIIB) buzz held subdued around 30.9 while the price drifted up 3.9% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 1.1M shares. Updated Oct 10, 2026. Over the last 7 trading days, BIIB gained 1.3%. Buzz activity in the recent week averaged 30.7 and was variable, swinging between 16.9 and 44.0. Recent volume is in line with the 30-day average, reflecting steady institutional and retail participation. Daily crowd sentiment leaned bullish on 16 of the 20 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for BIIB and 2110+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live BIIB sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Oct 10, 2026.
| Adanos signal | Hold |
|---|---|
| Analyst consensus | Strong Buy (22 / 12 / 1) |
| Crowd bullish (7d) | 43% |
| Avg price target | $238.18 |
| Most bullish source | News, 54% |
| Most bearish source | X, 25% |
| Sentiment spread | 29 pts |
| Mentions (7d) | 17 |
| Market cap | $32.27B |
| P/E · Forward P/E | 38.8 · 14.0 |
| EPS · Beta | $5.63 · 0.1 |
| Revenue (TTM) | $10.03B · 8% margin |
| Industry | Drug Manufacturers - General |
Based on aggregated sentiment from Reddit, X and News sources, Biogen (BIIB) currently carries an Adanos hold signal with 76/100 conviction. The current cross-source average reads 43% bullish across 3 active sources. Those sources contribute 17 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Biogen (BIIB) is fairly quiet with 2 mentions over the last 7 days; the 30-day context spans 1 tracked subreddits. The 7-day tone is 50% bullish; 3-day activity momentum is stable, suggesting steady attention.
The crowd reads bearish on Biogen (BIIB), averaging 43% bullish across 3 tracked sources over the last 7 days. The two ends of the range are News at 54% bullish and X at 25%, a 29-point spread. On the professional side, 22 of 35 analysts rate BIIB a buy.
Of the 35 analysts covering Biogen (BIIB), 22 rate it a buy, 12 a hold and 1 a sell, for a strong buy consensus. The average price target is $238.18. That puts the street ahead of the crowd, which averages 43% bullish.
Biogen (BIIB)'s cross-source average is bearish at 43% bullish. Source readings are split: 1 source leans bullish, 1 source leans bearish and 1 source sits at 50% bullish. Reddit reads 50% bullish, News reads 54% bullish and x coverage is the most negative at 25% bullish. The combined signal points to broad mixed pressure with 76/100 conviction.
The cross-source average is bearish for Biogen (BIIB) at 43% bullish. Source readings are split: 1 source leans bullish, 1 source leans bearish and 1 source sits at 50% bullish. The most bearish reading is x at 25% bullish. 3-day activity momentum is falling across News. The hold signal carries 76/100 conviction.
News is the dominant discussion channel with 11 mentions (65% of total volume). X contributes 4 mentions and Reddit contributes 2 mentions. The cross-source average is bearish at 43% bullish. Source readings are split: 1 source leans bullish, 1 source leans bearish and 1 source sits at 50% bullish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. BIIB's hold signal at 76/100 conviction reflects a bearish cross-source average at 43% bullish. Source readings are split: 1 source leans bullish, 1 source leans bearish and 1 source sits at 50% bullish. It is a research shortcut, not financial advice.
The BIIB sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Hold signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key